The objective is to highlight the clinical and social outcomes among adults who suffered
from Attention-Deficit Hyperactivity Disorder (ADHD) in their childhood/adolescence …

Attention deficit with or without hyperactivity disorder (ADHD) is one of the most frequent
neuropsychiatric disorders, and affects 2–4% of adults. In contrast with many European …

Epidemiological evidence demonstrates that cannabis use is associated with an increased
risk of psychotic outcomes, and confirms a dose‐response relationship between the level of …

Neurodevelopmental disorders (NDDs) encompass a group of complex conditions with
onset during the early developmental period. Such disorders are frequently associated with …

Abstract Introduction Treatments for Adult ADHD include stimulants, two non-stimulant
medications, as well as cognitive-behavioral therapy (CBT). These pharmacological agents …

Objective: People with ADHD are more likely to use cannabis but little is known about the
effects of cannabis on ADHD symptoms, ADHD medication side effects, or ADHD-related …

Attention-deficit hyperactivity disorder (ADHD) and substance use disorders (SUDs) may
have common etiologies. ADHD is more prevalent in patients with substance use disorders …

Background A valid screening instrument is needed to detect attention-deficit/hyperactivity
disorder (ADHD) in treatment-seeking borderline personality disorder (BPD) patients. We …

Background And Objective Many patients with cannabis use disorder (CUD) do not achieve
or do not have abstinence as a goal of treatment, rather they reduce their use. Assessing …

Background: Early identification of attention-deficit/hyperactivity disorder (ADHD) in
individuals with substance use disorders (SUD) is important because ADHD has an adverse …